The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
Open accessAbstract
BACKGROUND: Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system. Many findings suggest that the disease has an autoimmune pathogenesis; the target of the immune response is not yet known. METHODS: We screened serum IgG from persons with multiple sclerosis to identify antibodies that are capable of binding to brain tissue and observed specific binding of IgG to glial cells in a subgroup of patients. Using a proteomic approach focusing on membrane proteins, we identified the ATP-sensitive inward rectifying potassium channel KIR4.1 as the target of the IgG antibodies. We used a multifaceted validation strategy to confirm KIR4.1 as a target of the autoantibody response in multiple sclerosis and to show its potential pathogenicity in vivo. RESULTS: Serum levels of antibodies to KIR4.1 were higher in persons with multiple sclerosis than in persons with other neurologic diseases and healthy donors (P<0.001 for both comparisons). We replicated this finding in two independent groups of persons with multiple sclerosis or other neurologic diseases (P<0.001 for both comparisons). Analysis of the combined data sets indicated the presence of serum antibodies to KIR4.1 in 186 of 397 persons with multiple sclerosis (46.9%), in 3 of 329 persons with other neurologic diseases (0.9%), and in none of the 59 healthy donors. These antibodies bound to the first extracellular loop of KIR4.1. Injection of KIR4.1 serum IgG into the cisternae magnae of mice led to a profound loss of KIR4.1 expression, altered expression of glial fibrillary acidic protein in astrocytes, and activation of the complement cascade at sites of KIR4.1 expression in the cerebellum. CONCLUSIONS: KIR4.1 is a target of the autoantibody response in a subgroup of persons with multiple sclerosis. (Funded by the German Ministry for Education and Research and Deutsche Forschungsgemeinschaft.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Epilepsy, Ataxia, Sensorineural Deafness, Tubulopathy, and KCNJ10 Mutations
Bockenhauer, D., Feather, S., Stanescu, H. C., Bandulik, S., Zdebik, A. A., Reichold, M., Tobin, J., Lieberer, E., Sterner, C., Landoure, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810276 · Cited by 594
Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21802 · Cited by 590
Self-citationNeuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 563
Saadoun, S., Waters, P., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C. (2010) · Brain · doi:10.1093/brain/awp309 · Cited by 548
Scholl, U. I., Choi, M., Liu, T., Ramaekers, V. T., Häusler, M. G., Grimmer, J., Tobe, S. W., Farhi, A., Nelson-Williams, C., & Lifton, R. P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901749106 · Cited by 501
Nagelhus, E. A., Horio, Y., Inanobe, A., Fujita, A., Haug, F.-M., Nielsen, S., Kurachi, Y., & Ottersen, O. P. (1999) · Glia · doi:10.1002/(sici)1098-1136(199903)26:1<47::aid-glia5>3.0.co;2-5 · Cited by 474
Keegan, M., König, F., McClelland, R., Brück, W., Morales, Y., Bitsch, A., Panitch, H., Lassmann, H., Weinshenker, B., Rodriguez, M., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67102-4 · Cited by 433
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Storch, M. K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P., & Lassmann, H. (1998) · Annals of Neurology · doi:10.1002/ana.410430409 · Cited by 422
Amiry-Moghaddam, M., Williamson, A., Palomba, M., Eid, T., de Lanerolle, N. C., Nagelhus, E. A., Adams, M. E., Froehner, S. C., Agre, P., & Ottersen, O. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336064100 · Cited by 363
Homogeneity of active demyelinating lesions in established multiple sclerosis
Breij, E. C. W., Brink, B. P., Veerhuis, R., van den Berg, C., Vloet, R., Yan, R., Dijkstra, C. D., van der Valk, P., & Bö, L. (2008) · Annals of Neurology · doi:10.1002/ana.21311 · Cited by 353
Cepok, S., Zhou, D., Srivastava, R., Nessler, S., Stei, S., Büssow, K., Sommer, N., & Hemmer, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523661 · Cited by 323
Self-citationMeinl, E., Krumbholz, M., & Hohlfeld, R. (2006) · Annals of Neurology · doi:10.1002/ana.20890 · Cited by 310
Higashi, K., Fujita, A., Inanobe, A., Tanemoto, M., Doi, K., Kubo, T., & Kurachi, Y. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.3.c922 · Cited by 309
Kir4.1 Potassium Channel Subunit Is Crucial for Oligodendrocyte Development and In Vivo Myelination
Neusch, C., Rozengurt, N., Jacobs, R. E., Lester, H. A., & Kofuji, P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05429.2001 · Cited by 296
Quintana, F. J., Farez, M. F., Viglietta, V., Iglesias, A. H., Merbl, Y., Izquierdo, G., Lucas, M., Basso, A. S., Khoury, S. J., Lucchinetti, C. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806310105 · Cited by 241
Kucheryavykh, Y. V., Kucheryavykh, L. Y., Nichols, C. G., Maldonado, H. M., Baksi, K., Reichenbach, A., Skatchkov, S. N., & Eaton, M. J. (2007) · Glia · doi:10.1002/glia.20455 · Cited by 240
Seifert, G., Huttmann, K., Binder, D. K., Hartmann, C., Wyczynski, A., Neusch, C., & Steinhauser, C. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3790-08.2009 · Cited by 236
Glial heterogeneity in expression of the inwardly rectifying K+ channel, Kir4.1, in adult rat CNS
Poopalasundaram, S., Knott, C., Shamotienko, O. G., Foran, P. G., Dolly, J. O., Ghiani, C. A., Gallo, V., & Wilkin, G. P. (2000) · Glia · doi:10.1002/(sici)1098-1136(200006)30:4<362::aid-glia50>3.0.co;2-4 · Cited by 183
Sharma, R., Fischer, M.-T., Bauer, J., Felts, P. A., Smith, K. J., Misu, T., Fujihara, K., Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0704-z · Cited by 164
Unveiling the enigma of the CNS as a B-cell fostering environment
Uccelli, A., Aloisi, F., & Pistoia, V. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.02.009 · Cited by 101
Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury
Derfuss, T. J., Linington, C., Hohlfeld, R., & Meinl, E. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0632-3 · Cited by 89
Heterogeneity of Kir4.1 channel expression in glia revealed by mouse transgenesis
Tang, X., Taniguchi, K., & Kofuji, P. (2009) · Glia · doi:10.1002/glia.20882 · Cited by 77
Meningitis‐associated hearing loss: Protection by adjunctive antioxidant therapy
Klein, M., Koedel, U., Pfister, H., & Kastenbauer, S. (2003) · Annals of Neurology · doi:10.1002/ana.10684 · Cited by 76
Cortese, I., Tafi, R., Grimaldi, L. M. E., Martino, G., Nicosia, A., & Cortese, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11063 · Cited by 71
Archelos, J. J., Trotter, J., Previtali, S. C., Weißbrich, B., Toyka, K. V., & Hartung, H. (1998) · Annals of Neurology · doi:10.1002/ana.410430107 · Cited by 66
Autoantibody Profiling in Multiple Sclerosis Reveals Novel Antigenic Candidates
Somers, V. A., Govarts, C., Somers, K., Hupperts, R., Medaer, R., & Stinissen, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3957 · Cited by 62
Multiple sclerosis: Disease biomarkers as indicated by pathophysiology
Berger, T., & Reindl, M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.070 · Cited by 49
Variable loss of Kir4.1 channel function in SeSAME syndrome mutations
Tang, X., Hang, D., Sand, A., & Kofuji, P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.105 · Cited by 45
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Reactive Gliosis and the Multicellular Response to CNS Damage and Disease
Burda, J. E., & Sofroniew, M. V. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.034 · Cited by 1,438
Astrocyte barriers to neurotoxic inflammation
Sofroniew, M. V. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3898 · Cited by 1,202
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
The promise and challenge of high-throughput sequencing of the antibody repertoire
Georgiou, G., Ippolito, G. C., Beausang, J., Busse, C. E., Wardemann, H., & Quake, S. R. (2014) · Nature Biotechnology · doi:10.1038/nbt.2782 · Cited by 652
Metadata
- Authors
- Srivastava, R., Aslam, M., Kalluri, S. R., Schirmer, L., Buck, D., Tackenberg, B., Rothhammer, V., Chan, A., Gold, R., Berthele, A., Bennett, J. L., Korn, T., & Hemmer, B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-07-12
- Volume
- 367
- Issue
- 2
- Pages
- 115-123
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1970626055
- Cited by
- 343
- References
- 40
- FWCI
- 36.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.